Table 1: Clinical and functional characteristics of COPD patients admitted for acute pulmonary embolism (PE).

All patients Alive Dead p-value
Subject's n, (%) 33 (100) 24 (73) 9 (27)
Clinical Characteristics (mean ± SD)
Male/Female (n,)
Age (years)
Current Smokers n, (%)
Body Mass Index (Kg/m2)
mMRC scale*
AECOPD = 2/año (n,%) 		28/5
69(10)
10(30)
26(5)
2.33 (0.9)
5(15) 		20/4
70(9)
7(29)
27(5)
2.29 (0.9)
3(12) 		8/1
68(13)
3(33)
25(5)
2.44(0.2)
2(22) 		0.582
0.762
0.610
0.641
0.699
0.418
THROMBOSIS RISK FACTORS (N, %)
IMMOBILISATION
Cancer
Surgery within the last two moths
Personal history of VTE
Obesity
Chronic Heart Failure 		8(24)
10(30)
2(6)
5(18)
8(25)
3(9) 		5(20)
6(26)
1(4)
6(25)
7(30)
3(12) 		2(22)
4(44)
1(11)
0(0)
1(12)
0(0) 		0.626
0.275
0.447
0.122
0.311
0.357
Clinical presentation of PE (n, %)
Dyspnea
Chest pain
SaO2 below 90%
HR more than 100 beat/min
TAS below 100 mmHg 		27(82)
6(19)
10(30)
11(34)
1(3) 		20(83)
3(13)
6(26)
7(30)
1(4) 		7(78)
3(33)
4(44)
4(44)
0(0) 		0.533
0.203
0.275
0.362
0.719
Pulmonary Function (mean ± SD)*
FEV1/FVC (%)
FEV1 (% predicted)
DLco (%predicted)
TLC (%predicted)
RV/TLC (%)
PaO2 (mmHg)
PaCO2 (mmHg) 		49(14)
45(17)
66(23)
102(19)
58(12)
67(10)
44(9) 		50(15)
45(16)
72(25)
102(22)
59(12)
66(9)
43(6) 		49(13)
45(22)
51(6)
102(6)
56(12)
71(10)
46(12) 		0.914
0.963
0.002
0.968
0.636
0.127
0.213
 

*Measured during clinical stable condition previous PE. mMRC; AECOPD; VTE; HR; TAS; FEV1/FVC; FEV1; DLco: carbon monoxide diffusing capacity; TLC; RV/TLC;PaCO2: carbon dioxide arterial pressure; PaO2: oxygen arterial pressure; SaO2: arterial oxygen saturation